SCHEMBL5502763

SCHEMBL5502763

O=C1c2ccccc2C(=O)N1C1(O)CCCCC1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 12/20 0.48
HPGD P15428 6/20 0.46
KDM4E B2RXH2 6/20 0.46
HSD17B10 Q99714 4/20 0.46
SMN1; SMN2 Q16637 4/20 0.46
TSHR P16473 3/20 0.46
MAPK1 P28482 2/20 0.46
LMNA P02545 2/20 0.44
NPC1 O15118 2/20 0.40
RAB9A P51151 2/20 0.40
TP53 P04637 1/20 0.40
ALOX12 P18054 2/20 0.40
MAPT P10636 1/20 0.40
PKM P14618 1/20 0.40
ALOX15 P16050 1/20 0.40
MC4R P32245 1/20 0.40
CYP2C19 P33261 1/20 0.39
CA1 P00915 1/20 0.39
CA2 P00918 1/20 0.39
CASP1 P29466 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6659478 0.98 ALDH1A1 (0.49) ALDH1A1HPGDKDM4EHSD17B10SMN1; SMN2
SCHEMBL8074175 0.88 ALDH1A1 (0.43) ALDH1A1HPGDKDM4EHSD17B10SMN1; SMN2
SCHEMBL11360248 0.77 ALDH1A1 (0.44) ALDH1A1HPGDKDM4EHSD17B10SMN1; SMN2
SCHEMBL10806351 0.77 ALDH1A1 (0.44) ALDH1A1HPGDKDM4EHSD17B10SMN1; SMN2
SCHEMBL29885176 0.77 ALDH1A1 (0.67) ALDH1A1HPGDKDM4EHSD17B10SMN1; SMN2
SCHEMBL11611884 0.77 ALDH1A1 (0.67) ALDH1A1HPGDKDM4EHSD17B10SMN1; SMN2
SCHEMBL27560506 0.75 ALDH1A1 (0.43) ALDH1A1HPGDKDM4EHSD17B10SMN1; SMN2
SCHEMBL11610721 0.75 ALDH1A1 (0.57) ALDH1A1HPGDKDM4EHSD17B10SMN1; SMN2
SCHEMBL9845601 0.75 ALDH1A1 (0.57) ALDH1A1HPGDKDM4EHSD17B10SMN1; SMN2
SCHEMBL6662082 0.74 ALDH1A1 (0.45) ALDH1A1HPGDKDM4EHSD17B10SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20070123573-A1 Process for the preparation of biologically active tetrahydrobenzthiazole derivative ALEMBIC LIMITED (IN) 2007-05-31 US disclosed
EP-1761511-A1 IMPROVED PROCESS FOR THE PREPARATION OF BIOLOGICALLY ACTIVE TETRAHYDROBENZTHIAZOLE DERIVATIVE Alembic Limited (IN) 2007-03-14 EP disclosed
WO-2006003677-A1 IMPROVED PROCESS FOR THE PREPARATION OF BIOLOGICALLY ACTIVE TETRAHYDROBENZTHIAZOLE DERIVATIVE ALEMBIC LIMITED (IN) 2006-01-12 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070123573-A1 Process for the preparation of biologically active tetrahydrobenzthiazole derivative CA6, CA1, TPO ALDH1A1 46/4885HPGD 166/4885KDM4E 2473/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.